Lantern Pharma Inc. (LTRN) — SC 13D/A Filings
All SC 13D/A filings from Lantern Pharma Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Bios Equity Partners Amends Lantern Pharma Stake
— Mar 1, 2024 Risk: medium
Bios Equity Partners, LP, along with associated entities and individuals like Aaron Glenn and Louis Fletcher, filed an amendment on March 1, 2024, to their Sche
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX